
Parveen Kundu
About Parveen Kundu
Data last updated:
Parveen Kundu is a Designated Partner at Rohtak Nuclear Medcare Llp (since 2017), Director at Nuctherain Private Limited (since 2025) and Partner at Mitti Theranostics Llp (since 2022). The companies operate in Healthcare. The largest current company by reported revenue is Rohtak Nuclear Medcare Llp at ₹6.35 Cr (FY 2025). Earlier, Parveen Kundu was a Director at Nuclear Medsystems India Private Limited (2021–2022) and Designated Partner at Nuclear Medsystems India Llp (from 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 16 Oct 2017 | 2017 | ₹6.35 Cr (FY 2025) | Active | |
| Director | 18 Sep 2025 | 2025 | Active | ||
| Partner | 19 Dec 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Jun 2021 | 2021 | ₹14.46 Cr (FY 2024) | Active | |
| Designated Partner | 11 Dec 2017 | 2017 | Converted To Cmp And Dissolved |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Parveen Kundu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manju | 09661488 | Rohtak Nuclear Medcare Llp | Designated Partner |
| Sajni Devi | 09661739 | Rohtak Nuclear Medcare Llp | Designated Partner |
| Shubham Vashistha | 11305684 | Nuctherain Private Limited | Director |
| Amburanjan Santra | 10034462 | Mitti Theranostics Llp | Designated Partner |
| Papia Santra | 10034463 | Mitti Theranostics Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Parveen Kundu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parveen Kundu
Parveen Kundu currently holds 3 directorships: Rohtak Nuclear Medcare Llp (Designated Partner, since 16 Oct 2017, revenue βΉ6.35 Cr (FY 2025)); Nuctherain Private Limited (Director, since 18 Sep 2025); Mitti Theranostics Llp (Partner, since 19 Dec 2022).
Parveen Kundu was first appointed on 16 Oct 2017 as Designated Partner at Rohtak Nuclear Medcare Llp. The most recent appointment on record is 18 Sep 2025 at Nuctherain Private Limited.
Parveen Kundu held 2 earlier board appointments: Nuclear Medsystems India Private Limited (Director, 24 Jun 2021 to 01 Sep 2022); Nuclear Medsystems India Llp (Designated Partner, from 11 Dec 2017).
The current boards of Parveen Kundu's companies include Manju (Rohtak Nuclear Medcare Llp), Sajni Devi (Rohtak Nuclear Medcare Llp), Shubham Vashistha (Nuctherain Private Limited), Amburanjan Santra (Mitti Theranostics Llp), Papia Santra (Mitti Theranostics Llp).